Dr. Subramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Level 4 - White Oak Clinic
Fairfax, VA 22031Phone+1 571-472-1380Fax+1 571-472-1294
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2007 - 2010
St Luke's HospitalResidency, Internal Medicine, 2003 - 2006
Sri Ramachandra Medical CollegeClass of 2000
Certifications & Licensure
MO State Medical License 2006 - 2026
VA State Medical License 2021 - 2026
KS State Medical License 2015 - 2025
TN State Medical License 2012 - 2018- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Start of enrollment: 2011 Apr 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Impact of PROphet Test in Changing Physicians' Therapeutic Decision-Making for Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer.David R Gandara, Janakiraman Subramanian, Edgardo S Santos, Yehuda Brody, Itamar Sela
Clinical Lung Cancer. 2024-09-01 - Breaking barriers: patient-derived xenograft (PDX) models in lung cancer drug development-are we close to the finish line?Nagla Abdel Karim, Mohamed Zaza, Janakiraman Subramanian
Translational Lung Cancer Research. 2024-08-31 - The Number of Chemoimmunotherapy Cycles and Clinical Outcomes in Resectable NSCLC.Ben Ponvilawan, Janakiraman Subramanian, Dhruv Bansal
Journal of Thoracic Oncology. 2024-08-01
Press Mentions
The Role of Chemotherapy in the Treatment of Stage II Nasopharyngeal Carcinoma: Retrospective Analysis of the National Cancer DatabaseFebruary 21st, 2020
Genomic Testing Solves Cancer MisdiagnosisMarch 14th, 2019
Lantern Pharma Announces Positive Clinical Update from Ongoing Phase 2 HARMONIC™ Clinical Trial for Never Smokers with Advanced NSCLC, Including an 86% Clinical Benefit Rate in the Initial Patient CohortAugust 8th, 2024
Professional Memberships
- Member
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
